Abiopharma

🔍 Garman Matthew S (Executive)

Company: AMAZON COM INC (AMZN)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 4,860 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 19,019.00 | transaction_form_type: 4
• Acquired 1,480 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,499.00 | transaction_form_type: 4
• Acquired 4,000 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 24,499.00 | transaction_form_type: 4
• Acquired 7,836 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 32,335.00 | transaction_form_type: 4
• Sold 2,159 shares of Common Stock, par value $.01 per share at $257.5954 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,176.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,191 shares of Common Stock, par value $.01 per share at $258.6595 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,985.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 5,240 shares of Common Stock, par value $.01 per share at $259.5702 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,745.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,951 shares of Common Stock, par value $.01 per share at $260.3396 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,794.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Holds 0 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: Amazon.com 401(k) Plan Account | shares_owned_after: 887.52
• Sold 4,860 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2027-02-21 | Exercise: 2022-05-21 | equity_swap_involved: 0 | shares_owned_after: 9,720.00 | transaction_form_type: 4 | Footnotes: F6, F7
• Sold 1,480 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2028-02-21 | Exercise: 2023-05-21 | equity_swap_involved: 0 | shares_owned_after: 34,820.00 | transaction_form_type: 4 | Footnotes: F6, F8
• Sold 4,000 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2027-02-21 | Exercise: 2024-05-21 | equity_swap_involved: 0 | shares_owned_after: 8,000.00 | transaction_form_type: 4 | Footnotes: F6, F9
• Sold 7,836 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2030-02-21 | Exercise: 2025-05-21 | equity_swap_involved: 0 | shares_owned_after: 134,477.00 | transaction_form_type: 4 | Footnotes: F6, F10

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/04/2026.
• F2: Represents the weighted average sale price. The highest price at which shares were sold was $258.08 and the lowest price at which shares were sold was $257.09.
• F3: Represents the weighted average sale price. The highest price at which shares were sold was $259.09 and the lowest price at which shares were sold was $258.11.
• F4: Represents the weighted average sale price. The highest price at which shares were sold was $260.02 and the lowest price at which shares were sold was $259.11.
• F5: Represents the weighted average sale price. The highest price at which shares were sold was $260.79 and the lowest price at which shares were sold was $260.15.
• F6: Converts into Common Stock on a one-for-one basis.
• F7: This award vests based upon the following vesting schedule: 3,420 shares on each of May 21, 2022, August 21, 2022, and November 21, 2022; 3,400 shares on February 21, 2023; 3,640 shares on May 21, 2023; 3,620 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 4,300 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 6,320 shares on each of May 21, 2025 and August 21, 2025; 6,300 shares on each of November 21, 2025 and February 21, 2026; and 4,860 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, and February 21, 2027.
• F8: This award vests based upon the following vesting schedule: 8,260 shares on each of May 21, 2023 and August 21, 2023; 8,240 shares on each of November 21, 2023 and February 21, 2024; 3,180 shares on each of May 21, 2024, August 21, 2024, and November 21, 2024; 3,160 shares on February 21, 2025; 6,960 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 6,940 shares on February 21, 2026; 1,500 shares on May 21, 2026; 1,480 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,980 shares on May 21, 2027; and 7,960 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028.
• F9: This award vests based upon the following vesting schedule: 4,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, February 21, 2025, May 21, 2026, August 21, 2026, November 21, 2026, and February 21, 2027.
• F10: This award vests based upon the following vesting schedule: 7,643 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 7,836 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 7,835 shares on February 21, 2027; 7,845 shares on each of May 21, 2027 and August 21, 2027; 7,844 shares on each of November 21, 2027 and February 21, 2028; 12,344 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 12,343 shares on February 21, 2029; 9,514 shares on May 21, 2029; and 9,513 shares on each of August 21, 2029, November 21, 2029, and February 21, 2030.
• REMARKS: The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.